Switch theme
Sign up to access all valuation multiples
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
2011
229
LTM Revenue $84.1M
LTM EBITDA -$67.9M
$145M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Personalis has a last 12-month revenue of $84.1M and a last 12-month EBITDA of -$67.9M.
In the most recent fiscal year, Personalis achieved revenue of $84.6M and an EBITDA of -$70.3M.
Personalis expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Personalis valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $73.5M | $84.6M | XXX | XXX | XXX |
| Gross Profit | $13.3M | $18.2M | XXX | XXX | XXX |
| Gross Margin | 18% | 22% | XXX | XXX | XXX |
| EBITDA | -$96.8M | -$70.3M | XXX | XXX | XXX |
| EBITDA Margin | -132% | -83% | XXX | XXX | XXX |
| Net Profit | -$113M | -$108M | XXX | XXX | XXX |
| Net Margin | -154% | -128% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Personalis's stock price is $3.
Personalis has current market cap of $286M, and EV of $145M.
See Personalis trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $145M | $286M | XXX | XXX | XXX | XXX | $-1.27 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Personalis has market cap of $286M and EV of $145M.
Personalis's trades at 1.7x LTM EV/Revenue multiple, and -2.1x LTM EBITDA.
Analysts estimate Personalis's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Personalis and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $145M | XXX | XXX | XXX |
| EV/Revenue | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | -2.1x | XXX | XXX | XXX |
| P/E | -3.5x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -3.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpPersonalis's NTM/LTM revenue growth is 7%
Personalis's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.4M for the same period.
Over next 12 months, Personalis's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Personalis's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Personalis and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 15% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -83% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -27% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -76% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.4M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.4M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 58% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 112% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Epigenomics | XXX | XXX | XXX | XXX | XXX | XXX |
| ToolGen | XXX | XXX | XXX | XXX | XXX | XXX |
| 4basebio | XXX | XXX | XXX | XXX | XXX | XXX |
| Genus | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Personalis acquired XXX companies to date.
Last acquisition by Personalis was XXXXXXXX, XXXXX XXXXX XXXXXX . Personalis acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Personalis founded? | Personalis was founded in 2011. |
| Where is Personalis headquartered? | Personalis is headquartered in United States of America. |
| How many employees does Personalis have? | As of today, Personalis has 229 employees. |
| Who is the CEO of Personalis? | Personalis's CEO is Mr. Christopher Hall. |
| Is Personalis publicy listed? | Yes, Personalis is a public company listed on NAS. |
| What is the stock symbol of Personalis? | Personalis trades under PSNL ticker. |
| When did Personalis go public? | Personalis went public in 2019. |
| Who are competitors of Personalis? | Similar companies to Personalis include e.g. EZZ Life Science, Epigenomics, ToolGen, 4basebio. |
| What is the current market cap of Personalis? | Personalis's current market cap is $286M |
| What is the current revenue of Personalis? | Personalis's last 12-month revenue is $84.1M. |
| What is the current EBITDA of Personalis? | Personalis's last 12-month EBITDA is -$67.9M. |
| What is the current EV/Revenue multiple of Personalis? | Current revenue multiple of Personalis is 1.7x. |
| What is the current EV/EBITDA multiple of Personalis? | Current EBITDA multiple of Personalis is -2.1x. |
| What is the current revenue growth of Personalis? | Personalis revenue growth between 2023 and 2024 was 15%. |
| Is Personalis profitable? | Yes, Personalis is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
